Volume 68, Issue 7 e28940
ONCOLOGY: RESEARCH ARTICLE

Presentation acuity, induction mortality, and resource utilization in infants with acute leukemia

Azada Ibrahimova

Azada Ibrahimova

Department of Pediatrics and Adolescent Medicine, Einstein Healthcare Network Philadelphia, Philadelphia, Pennsylvania, USA

Search for more papers by this author
Lena E. Winestone

Lena E. Winestone

Division of AIBMT, Department of Pediatrics, UCSF Benioff Children's Hospital, San Francisco, California, USA

Search for more papers by this author
Tamara P. Miller

Tamara P. Miller

Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta, Atlanta, Georgia, USA

Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia, USA

Search for more papers by this author
Kyle Kettler

Kyle Kettler

Drexel University College of Medicine, Philadelphia, Pennsylvania, USA

Search for more papers by this author
Alix E. Seif

Alix E. Seif

Division of Oncology, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA

Search for more papers by this author
Yuan-Shung Huang

Yuan-Shung Huang

Center for Pediatric Clinical Effectiveness, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA

Search for more papers by this author
Caitlin W. Elgarten

Caitlin W. Elgarten

Division of Oncology, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA

Center for Pediatric Clinical Effectiveness, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA

Search for more papers by this author
Regina M. Myers

Regina M. Myers

Division of Oncology, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA

Search for more papers by this author
Brian T. Fisher

Brian T. Fisher

Center for Pediatric Clinical Effectiveness, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA

Perelman School of Medicine, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, USA

Division of Infectious Diseases, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA

Search for more papers by this author
Richard Aplenc

Richard Aplenc

Division of Oncology, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA

Center for Pediatric Clinical Effectiveness, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA

Perelman School of Medicine, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, USA

Search for more papers by this author
Kelly D. Getz

Corresponding Author

Kelly D. Getz

Division of Oncology, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA

Center for Pediatric Clinical Effectiveness, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA

Perelman School of Medicine, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, USA

Correspondence

Kelly D. Getz, University of Pennsylvania Perelman School of Medicine, 423 Guardian Dr, Blockley Hall 909, Philadelphia, PA 19104, USA.

Email: [email protected]

Search for more papers by this author
First published: 11 March 2021
Citations: 1

Azada Ibrahimova and Lena E. Winestone contributed equally to this study.

This work was presented in part as a poster at the annual meeting of the American Society of Pediatric Hematology/Oncology (ASPHO), May 2018.

Abstract

Background

Treatment of infants with acute leukemia remains challenging, especially for acute lymphocytic leukemia (ALL). Infants have shown markedly higher rates of induction mortality compared with noninfants. There are limited data on presentation acuity and supportive care utilization in this age group.

Methods

In retrospective analyses of patients treated for new onset ALL or acute myeloid leukemia (AML) at pediatric hospitals contributing to the Pediatric Health Information System, we compared presentation acuity, induction mortality, and resource utilization in infants relative to noninfants less than 10 years at diagnosis.

Results

Analyses included 10 359 children with ALL (405 infants, 9954 noninfants) and 871 AML (189 infants, 682 noninfants). Infants were more likely to present with multisystem organ failure compared to noninfants for both ALL (12% and 1%, PR = 10.8, 95% CI: 7.4, 15.7) and AML (6% vs. 3%; PR = 2.0, 95% CI: 1.0, 3.7). Infants with ALL had higher induction mortality compared to noninfants, even after accounting for differences in anthracycline exposure and presentation acuity (2.7% vs. 0.5%, HR = 2.1, 95% CI: 1.0, 4.8). Conversely, infants and noninfants with AML had similar rates of induction mortality (3.2% vs. 2.1%, HR = 1.2, 95% CI: 0.3, 3.9), which were comparable to rates among infants with ALL. Infants with ALL and AML had greater requirements for blood products, diuretics, supplemental oxygen, and ventilation during induction relative to noninfants.

Conclusions

Infants with leukemia present with higher acuity compared with noninfants. Induction mortality and supportive care requirements for infants with ALL were similar to all children with AML, and significantly higher than those for noninfants with ALL.

CONFLICT OF INTEREST

Authors had no conflicts to declare.

DATA AVAILABILITY STATEMENT

The data that support the findings of this study are available from the Children's Hospital Association. Restrictions apply to the availability of these data. Data are available from the authors with the permission of Children's Hospital Association.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.